Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anetta Undas

Showing results (491-500 of 652) with videos related to

Pageof 66
Sort By:
The Cochrane Database of Systematic Reviews|July 14, 2018
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodiesMalgorzata M Bala, Elżbieta Paszek, Wiktoria Lesniak, et al.
Journal of Crohn'S & Colitis|January 21, 2012
Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases TAFIa level in patients with IBDDanuta Owczarek, Anetta Undas, Jonathan H Foley, et al.
Journal of Thrombosis and Haemostasis : JTH|November 5, 2025
Higher citrullinated histone H3 is associated with postthrombotic syndrome: a cohort studyJulia Krupa-Zabiegała, Patryk Stanisław Michel, Konrad Stępień, et al.
Journal of Thrombosis and Thrombolysis|September 27, 2025
Protein carbonylation as a modulator of fibrin clot properties in thyroid disorders: impact of therapyKamila W Undas, Julianna Dąbrowa, Joanna Natorska, et al.
The Canadian Journal of Cardiology|June 29, 2025
Long-lasting Rivaroxaban Use Is Associated With Lower Aortic Valve Leaflet Calcification in Severe Aortic StenosisMagdalena Kopytek, Jacek Tarasiuk, Sebastian Wroński, et al.
Thrombosis and Haemostasis|October 12, 2012
Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of diseasePrzemyslaw Kapusta, Ewa Wypasek, Joanna Natorska, et al.
Clinical Chemistry and Laboratory Medicine|October 24, 2012
Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosisRenata Kolasa-Trela, Korneliusz Fil, Marta Bazanek, et al.
Thrombosis Research|November 27, 2019
Sex-specific alteration to α2-antiplasmin incorporation in patients with type 2 diabetesAgata Hanna Bryk, Jakub Siudut, Elżbieta Broniatowska, et al.
Stroke|October 5, 2023
Protein Carbonylation Contributes to Prothrombotic Fibrin Clot Phenotype in Acute Ischemic Stroke: Clinical AssociationsMichał Błaż, Joanna Natorska, Jan P Bembenek, et al.
Journal of Thrombosis and Thrombolysis|January 27, 2019
Unfavourably altered plasma clot properties in patients with primary Raynaud's phenomenon: association with venous thromboembolismJoanna Żuk, Agnieszka Snarska-Drygalska, Krzysztof Piotr Malinowski, et al.
Pageof 66

Showing results (491-500 of 652) with videos related to

Sort By:
Pageof 66
The Cochrane Database of Systematic Reviews|July 14, 2018
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodiesMalgorzata M Bala, Elżbieta Paszek, Wiktoria Lesniak, et al.
Journal of Crohn'S & Colitis|January 21, 2012
Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases TAFIa level in patients with IBDDanuta Owczarek, Anetta Undas, Jonathan H Foley, et al.
Journal of Thrombosis and Haemostasis : JTH|November 5, 2025
Higher citrullinated histone H3 is associated with postthrombotic syndrome: a cohort studyJulia Krupa-Zabiegała, Patryk Stanisław Michel, Konrad Stępień, et al.
Journal of Thrombosis and Thrombolysis|September 27, 2025
Protein carbonylation as a modulator of fibrin clot properties in thyroid disorders: impact of therapyKamila W Undas, Julianna Dąbrowa, Joanna Natorska, et al.
The Canadian Journal of Cardiology|June 29, 2025
Long-lasting Rivaroxaban Use Is Associated With Lower Aortic Valve Leaflet Calcification in Severe Aortic StenosisMagdalena Kopytek, Jacek Tarasiuk, Sebastian Wroński, et al.
Thrombosis and Haemostasis|October 12, 2012
Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of diseasePrzemyslaw Kapusta, Ewa Wypasek, Joanna Natorska, et al.
Clinical Chemistry and Laboratory Medicine|October 24, 2012
Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosisRenata Kolasa-Trela, Korneliusz Fil, Marta Bazanek, et al.
Thrombosis Research|November 27, 2019
Sex-specific alteration to α2-antiplasmin incorporation in patients with type 2 diabetesAgata Hanna Bryk, Jakub Siudut, Elżbieta Broniatowska, et al.
Stroke|October 5, 2023
Protein Carbonylation Contributes to Prothrombotic Fibrin Clot Phenotype in Acute Ischemic Stroke: Clinical AssociationsMichał Błaż, Joanna Natorska, Jan P Bembenek, et al.
Journal of Thrombosis and Thrombolysis|January 27, 2019
Unfavourably altered plasma clot properties in patients with primary Raynaud's phenomenon: association with venous thromboembolismJoanna Żuk, Agnieszka Snarska-Drygalska, Krzysztof Piotr Malinowski, et al.
Pageof 66